NFKB1 and myasthenia gravis: These results indicate that MG may disrupt TJs by activating the TNF-α-NF-κB/MLCK pathway, resulting in increased epithelial permeability, compromised epithelial barrier integrity, and cilia shedding, which promotes the migration of MG within tissues.